Home

Pathology

Alzheimer's Disease

Read time: 2 min

Congress highlights

Measuring tau accumulation and progression

The ability of PET to map regional changes in tau pathology over time provides important insights...

Read time: 4 min

Prevention key to reducing suicide deaths

Leading expert John Mann, Department of Psychiatry, Columbia University, New York, USA, raises...

Alzheimer's Disease

Read time: 2 min

Congress highlights

Synaptic stimulation protects against pathologic tau

Models of Alzheimer’s disease cast new light on the therapeutic potential of synaptic...

Alzheimer's Disease

Read time: 3 min

Congress highlights

Imaging biomarkers can contribute to prevention

Heterogeneity of pathology in mild cognitive impairment and Alzheimer’s disease poses major...

Alzheimer's Disease

Read time: 2 min

Congress highlights

Modulating the microbiome: a revolution in the making?

Altering the intestinal flora can influence host immunity, neuro-inflammation, and the deposition...

Depression, Schizophrenia

Read time: 2 min

Congress highlights

Roadmap for research and care

Precision medicine is essential to the optimization of care for individual patients, but also in...

Read time: 4 min

Congress highlights

CGRP – new perspectives in headache management

Three new takes on the potential for calcitonin gene-related proteins were presented at this year...

Read time: 2 min

Congress highlights

What lies beneath cognitive dysfunction in bipolar disorder?

Cognitive dysfunction associated with bipolar disorder is a strong predictor of disability and poor...

Maintaining functioning in bipolar disorder: Treat early and prevent relapses

Read the full article here.

Maintaining functioning in bipolar disorder: Treat early and prevent relapses

Read time: 3 min

Congress highlights

What causes the different phases of migraine?

Migraine is a complex neurological disorder characterized by a prodromal phase, aura, headache,...

Alzheimer's Disease

Read time: 2 min

Congress highlights

TDP-43: a newly-recognized route to cognitive decline

There is growing clinical interest in TDP-43 proteinopathy, a relatively recent and fast-moving...

Read time: 3 min

Congress highlights

New targets for migraine — CGRP, PACAP and electric activity

Emerging therapies for episodic and chronic migraine include monoclonal antibodies targeting the...

Country selection

We are registering that you are located in Brazil - if that's correct then please continue to Progress in Mind Brazil

Not located in Brazil?
Go to a different regional HUB

Continue to Progress in Mind Continue to Progress in Mind Brazil Continue to Progress in Mind Spain Continue to Progress in Mind Italy Continue to Progress in Mind

You are leaving Progress in Mind

Continue to

Cancel

Hello
Please confirm your email

We have just sent you an email, with a confirmation link.
Before you can gain full access - you need to confirm your email.

The information on this site is exclusively intented for health care professionals.

All the information included in the Website is related to products of the local market and, therefore, directed to health professionals legally authorized to prescribe or dispense medications with professional practice. The technical information of the drugs is provided merely informative, being the responsibility of the professionals authorized to prescribe drugs and decide, in each concrete case, the most appropriate treatment to the needs of the patient.

Accept

Decline

Congress

Register for access to Progress in Mind in your country